Cisplatin
Indication
It is the first-line drug for the treatment of various solid tumors. Combination with VP-16 (EP regimen) is the first-line treatment for SCLC or NSCLC. Combination with MMC, IFO (IMP regimen), or NVB is the commonly used regimen for the treatment of NSCLC. Combination chemotherapy based on DDP is also the main treatment for advanced ovarian cancer, osteosarcoma and neuroblastoma. Combination with ADM, CTX, etc. is effective for squamous cell carcinoma and transitional cell carcinoma in multiple sites, such as head and neck, cervical, esophageal and urinary system tumors.
Precautions
It is contraindicated for patients with renal impairment, severe bone marrow suppression, a history of allergy to this product and pregnant women.
Special Population Medication
Precautions during pregnancy and lactation: Contraindicated for use during pregnancy.
Manufacturer
-
Founded in:
1992-08-21 -
Address:
No. 317, Xinluo Street, High-tech Zone, Jinan City, Shandong Province -
Tax NO.:
91370000614073351Q -
Registered Funds:
600 million yuan -
Website:
-
Email: